Valuation Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. 30/10/2026			5-day change	1st Jan Change
1,305.00 ^ARS	+0.38%		-3.33%	-33.92%

06/08	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
11/05	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	9,327	17,927	31,412	56,405	1,44,949	1,59,484
Change	-	92.21%	75.23%	79.56%	156.98%	10.03%
Enterprise Value (EV) ¹	10,516	22,242	50,309	1,49,735	2,78,596	3,90,519
Change	-	111.5%	126.19%	197.63%	86.06%	40.17%
P/E	19.2x	30.3x	193x	-5.2x	6.08x	51.6x
PBR	2.76x	3.39x	3.11x	2.5x	2.25x	1.74x
PEG	-	1.4x	-2.7x	0x	-0x	-0.6x
Capitalization / Revenue	1.51x	1.08x	1.7x	1.45x	1.58x	1.26x
EV / Revenue	1.7x	1.34x	2.72x	3.84x	3.04x	3.08x
EV / EBITDA	6.66x	8.95x	15.1x	23.2x	15.3x	11.8x
EV / EBIT	7.07x	9.58x	16.9x	28.3x	17.9x	13.1x
EV / FCF	-27.8x	-9.98x	-5.19x	58x	-49x	-7.4x
FCF Yield	-3.59%	-10%	-19.3%	1.72%	-2.04%	-13.5%
Dividend per Share ²	0.5547	-	-	-	26.89	-
Rate of return	0.48%	-	-	-	1.5%	-
EPS ²	6.02	7.32	2.02	-134.4	295.3	38.24
Distribution rate	9.21%	-	-	-	9.11%	-
Net sales ¹	6,181	16,616	18,470	39,028	91,794	1,26,726
EBITDA ¹	1,578	2,486	3,326	6,441	18,249	32,999
EBIT ¹	1,487	2,322	2,982	5,299	15,565	29,906
Net income ¹	486.2	591.5	163.4	-10,851	23,845	3,088
Net Debt ¹	1,189	4,315	18,897	93,330	1,33,647	2,31,035
Reference price ²	115.50	222.00	389.00	698.50	1,795.00	1,975.00
Nbr of stocks (in thousands)	80,751	80,751	80,751	80,751	80,751	80,751
Announcement Date	10/03/21	09/03/22	09/03/23	11/03/24	07/03/25	06/03/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LABORATORIOS RICHMOND S.A.C.I.F.	-	-	-	-	6.85Cr
ELI LILLY AND COMPANY	41.42x	14.04x	31.11x	0.48%	1,26300Cr
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	66TCr
ABBVIE INC.	36.71x	8.6x	17.71x	2.33%	52TCr
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	39TCr
MERCK & CO., INC.	106.24x	6.06x	25.8x	2.28%	37TCr
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	31TCr
ASTRAZENECA PLC	24.47x	4.89x	13.59x	1.77%	29TCr
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	25TCr
GILEAD SCIENCES, INC.	-41.18x	7.46x	46.76x	1.93%	21TCr
Average	31.35x	7.39x	21.65x	2.01%	42.62TCr
Weighted average by Cap.	37.16x	8.83x	22.81x	1.69%